Wong Sandy, Cao Cheng, Lessio Martina, Stenzel Martina H
School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia.
Nanoscale. 2022 Jul 7;14(26):9448-9458. doi: 10.1039/d2nr01795d.
Many drug delivery carriers reported in the literature require multistep assembly or often have very low drug loading capacities. Here, we present a simple sugar-based strategy that feeds the increased interest in high-loading nanomedicine. The driving force of the supramolecular nanocapsule formation is the interaction between curcumin (CCM) and the monosaccharide fructose. Drug and sugar are simply mixed in an aqueous solution in an open vessel, followed by coating the nanocapsules with polydopamine (PDA) to maintain structural integrity. We show that nanocapsules can still be obtained when other drugs are added, producing dual-drug nanoparticles with sizes of around 150-200 nm and drug loading contents of around 90% depending on the thickness of the PDA shell. This concept is widely applicable for a broad variety of drugs, as long as the drug has similar polarities to CCM. The key to success is the interaction of CCM and the second drug as shown in computational studies. The drug was able to be released from the nanocapsule at a release rate that could be fine-tuned by adjusting the thickness of the PDA layer.
文献中报道的许多药物递送载体需要多步组装,或者通常具有非常低的载药量。在此,我们提出一种基于糖的简单策略,以满足对高载量纳米药物日益增长的兴趣。超分子纳米胶囊形成的驱动力是姜黄素(CCM)与单糖果糖之间的相互作用。药物和糖在开放容器中的水溶液中简单混合,然后用聚多巴胺(PDA)包覆纳米胶囊以维持结构完整性。我们表明,当添加其他药物时仍可获得纳米胶囊,根据PDA壳层的厚度,可产生尺寸约为150 - 200 nm且载药含量约为90%的双药纳米颗粒。只要药物与CCM具有相似的极性,这一概念就广泛适用于多种药物。如计算研究所示,成功的关键在于CCM与第二种药物的相互作用。药物能够以可通过调节PDA层厚度进行微调的释放速率从纳米胶囊中释放出来。